This prospective study features a simple and highly successful strategy for identifying occult malignant tumor before biopsy in patients with skeletal metastases of unknown origin. From The Journal of Bone & Joint Surgery.
This resource provides helpful patient education on bone metastases in advanced and metastatic cancer, including signs and symptoms and various treatment options.
Patients can learn about myriad aspects of bone health and cancer, including diagnostic tests, treatments, preventative measures, and the importance of dental care during cancer treatment.
These guidelines provide an update on the key recommendations of the American Society of Clinical Oncology (ASCO) guideline on the role of bone-modifying agents (BMAs) in metastatic breast cancer, specifically addressing new data on dosing intervals and the role BMAs play in controlling bone pain.
These ESMO guidelines provide a framework for maintaining bone health in patients with cancer, including diagnosis and monitoring, metastasis prevention, and cancer treatment–induced bone loss.
Review consensus statements on the assessment and management of bone disease, pain, and mobility among patients with multiple myeloma, including a patient education tip sheet for managing bone health in multiple myeloma.
Published in Frontiers in Oncology, this clinical review article on the use of bisphosphonate zoledronic acid and denosumab in reducing skeletal-related events in treating bone metastases.
These guidelines—from the Multinational Association of Supportive Care in Cancer, International Society of Oral Oncology, and American Society of Clinical Oncology—provide recommendations and best practices for the prevention and management of medication-related osteonecrosis of the jaw (MRONJ) in patients with cancer.
This patient resource from MD Anderson Cancer Center provides information about bone health in specific cancer populations, including breast, prostate, and hematologic cancers.
In this video roundtable discussion, moderator Carrie Tompkins Stricker and her colleagues weigh in on the advanced practitioner’s role in the management of bone health and the options for bone-modifying agents in the oncology setting. Learn from panel members in diverse roles as they share their experience and expertise through cases illustrating the nuances of the advanced practice role.
Published in the Journal of Clinical Oncology, this update to the American Society of Clinical Oncology (ASCO)-Ontario Health (Cancer Care Ontario [CCO]) adjuvant bone-modifying agents in breast cancer guideline addresses which patients should be treated with bone-modifying agents; recommended bisphosphonates for adjuvant therapy and optimal doses, durations, and routes; and the role of denosumab as adjuvant therapy, among other important clinical questions.
Created by Amgen, this patient-focused website provides information and resources on bone metastases, serious bone problems, and protecting bone health, as well as a discussion guide for talking about bone metastases with their healthcare team.
This patient education resource discusses the connection between chemotherapy and bone pain, complications of bone pain, and approaches to minimizing bone pain, including mediations.
Check out ClinicalTrials.gov to find ongoing and completed clinical trials involving patients with bone metastases.
